Joelle Dountio Ofimboudem

Featured in: Favicon

Articles

Accessible DAAs Shouldn't Be DOA: Delivering on the Promise of Negotiated Price Reductions for HCV Treatment – hepCoalition

Nov 26, 2024 | hepcoalition.org | Ana Balkandjieva |Joelle Dountio Ofimboudem

The hepatitis C Virus (HCV) remains one of the deadliest infectious diseases, despite the existence of an effective eight-to-twelve week cure. Still, of the 50 million people estimated to be living with HCV worldwide, 36 percent were diagnosed between 2015 and 2022, and only around 20 percent received treatment. Access to direct acting antivirals (DAAs) must be urgently expanded to save lives.
Accessible DAAs Shouldn't Be DOA: Delivering on the Promise of Negotiated Price Reductions for HCV Treatment – Treatment Action Group

Nov 22, 2024 | treatmentactiongroup.org | Joelle Dountio Ofimboudem

By Joelle Dountio OfimboudemThe hepatitis C Virus (HCV) remains one of the deadliest infectious diseases, despite the existence of an effective eight- to-twelve week cure. Still, of the 50 million people estimated to be living with HCV worldwide, 36 percent were diagnosed between 2015 and 2022, and only around 20 percent received treatment. Access to direct acting antivirals (DAAs) must be urgently expanded to save lives.

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.